Synthetic Studies on the Viridin Skeleton through Regio- and Stereoselective Functionalization of the AE-Ring Moiety

Shuhei Hori; Sho Ishida; Go Itoh; Koji Sugiyama; Chiharu Yuki; Masahiro Egi; Kenzo Yahata; Takashi Ikawa; Shuji Akai

doi:10.1055/a-1527-3781

Synlett, Inhaltsverzeichnis

Synlett 2021; 32(12): 1187-1191
DOI: 10.1055/a-1527-3781

letter

Synthetic Studies on the Viridin Skeleton through Regio- and Stereoselective Functionalization of the AE-Ring Moiety

Shuhei Hori

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

,

Sho Ishida

^bSchool of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka 422-8526, Japan

,

Go Itoh

^bSchool of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka 422-8526, Japan

,

Koji Sugiyama

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

,

Chiharu Yuki

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

,

Masahiro Egi

^cGraduate Division of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka 422-8526, Japan

,

Kenzo Yahata

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

,

Takashi Ikawa

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

,

Shuji Akai ∗

^aGraduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka 1-6, Suita, Osaka 565-0871, Japan

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

4,5,6,7-Tetrahydroisobenzofurans, corresponding to the AC(D)E ring structure of viridin and equipped with required substituents on the A-ring, were synthesized with high regio- and stereoselectivities via the Diels–Alder adduct of a furan derivative and maleic anhydride. The key steps of this work include the regioselective opening of a tetrahydrofuran ring, a stereoselective epoxidation, and an AlMe₃-mediated regioselective epoxide opening followed by stereoselective C-methylation.

Key words

Diels–Alder reaction - regioselectivity - ring cleavage - tetrahydroisobenzofuran - viridin - furanosteroids

Volltext

Referenzen

References and Notes
1 Present addresses: Kenzo Yahata; Max-Planck-Institut für Kohlenforschung, 45470 Mülheim an der Ruhr, Germany. Takashi Ikawa; Gifu Pharmaceutical University, Daigaku-Nishi, Gifu 501–1196, Japan.
2 Brian PW, McGowan JG. Nature 1945; 156: 144
3 Moffatt JS, Bu’lock JD, Tuen TH. J. Chem. Soc. D. 1969; 839a
4 Brian PW, Curtis PJ, Hemming HG, Norris GL. F. Trans. Br. Mycol. Soc. 1957; 40: 365
5 Chen Y, Wang B.-C, Xiao Y. J. Cell. Physiol. 2012; 227: 2818
6 Aydin E, Faehling S, Saleh M, Llaó Cid L, Seiffert M, Roessner PM. Front. Immunol. 2020; 11: 595818

7a Wipf P, Halter RJ. Org. Biomol. Chem. 2005; 3: 2053
7b Norman BH, Shih C, Toth JE, Ray JE, Dodge JA, Johnson DW, Rutherford PG, Schultz RM, Worzalla JF, Vlahos CJ. J. Med. Chem. 1996; 39: 1106
7c Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ. Cancer Res. 1994; 54: 2419

For total syntheses of 3, see:

8a Guo Y, Quan T, Lu Y, Luo T. J. Am. Chem. Soc. 2017; 139: 6815
8b Shigehisa H, Mizutani T, Tosaki S, Ohshima T, Shibasaki M. Tetrahedron 2005; 61: 5057
8c Mizutani T, Honzawa S, Tosaki S, Shibasaki M. Angew. Chem. Int. Ed. 2002; 41: 4680

9a Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L. Clin. Genitourin. Cancer 2019; 17: 201
9b Howes AL, Chiang GG, Lang ES, Ho CB, Powis G, Vuori K, Abraham RT. Mol. Cancer Ther. 2007; 6: 2505
9c Wipf P, Minion DJ, Halter RJ, Berggren MI, Ho CB, Chiang GG, Kirkpatrick L, Abraham R, Powis G. Org. Biomol. Chem. 2004; 2: 1911

For reviews, see:

10a Senapati BK. Org. Chem. Front. 2021; 8: 2608
10b Xue D, He H, Gao S. Chem. Lett. 2021; 50: 497
10c Jacobi PA, Könekamp T, Mascall KC, O’Connor RT, Onyango EO, Sessions EH. Adv. Heterocycl. Chem. 2013; 110: 119

11a Mascall KC, Jacobi PA. Heterocycles 2014; 88: 1527
11b Onyango EO, Jacobi PA. Synth. Commun. 2013; 43: 2748
11c Onyango EO, Jacobi PA. J. Org. Chem. 2012; 77: 7411
11d Mascall KC, Jacobi PA. Tetrahedron Lett. 2012; 53: 1620
11e Viswanathan K, Ononye SN, Cooper HD, Hadden MK, Anderson AC, Wright DL. Bioorg. Med. Chem. Lett. 2012; 22: 6919
11f Findlay AD, Gebert A, Cade IA, Banwell MG. Aust. J. Chem. 2009; 62: 1173
11g Lang Y, Souza FE. S, Xu X, Taylor NJ, Assoud A, Rodrigo R. J. Org. Chem. 2009; 74: 5429
11h Yuan H, Pupo MT, Blois J, Smith A, Weissleder R, Clardy J, Josephson L. Bioorg. Med. Chem. Lett. 2009; 19: 4223
11i Muller KM, Keay BA. Synlett 2008; 1236
11j Sessions EH, Jacobi PA. Org. Lett. 2006; 8: 4125
11k Souza FE. S, Rodrigo R. Chem. Commun. 1999; 1947

12 Anderson EA, Alexanian EJ, Sorensen EJ. Angew. Chem. Int. Ed. 2004; 43: 1998
13 Del Bel M, Abela AR, Ng JD, Guerrero CA. J. Am. Chem. Soc. 2017; 139: 6819
14 Ji Y, Xin Z, He H, Gao S. J. Am. Chem. Soc. 2019; 141: 16208
15 Creemer LC, Kirst HA, Vlahos CJ, Schultz RM. J. Med. Chem. 1996; 39: 5021
16 Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL. Mol. Cell 2000; 6: 909
17 Akai S, Naka T, Omura S, Tanimoto K, Imanishi M, Takebe Y, Matsugi M, Kita Y. Chem. Eur. J. 2002; 8: 4255
18 All position numbers used in this paper correspond to those of compound 1.
19 The stereochemistry of compound 8 was determined from its NMR data and also by comparison of the NMR data with those of related compounds, see: Buts, T.; Sauer, J. Tetrahedron: Asymmetry 1997 , 8, 703; and ref. 17 (see also the SI).
20 The translactonization occurred twice during the conversion of 8 into 10, as shown in Scheme 2. The stereochemical structure of 9 was determined by comparison of the ¹H NMR data for 8, 9, and 10 (for details, see SI).

21a Terayama N, Yasui E, Mizukami M, Miyashita M, Nagumo S. Org. Lett. 2014; 16: 2794
21b Reddy GV, Kumar RS. C, Siva B, Babu KS, Rao JM. Synlett 2012; 23: 2677
21c Boeckman RK. Jr, Shao P, Wrobleski ST, Boehmler DJ, Heintzelman GR, Barbosa AJ. J. Am. Chem. Soc. 2006; 128: 10572
21d Nicolaou KC, Kim DW, Schlawe D, Lizos DE, de Noronha RG, Longbottom DA. Angew. Chem. Int. Ed. 2005; 44: 4925
21e Boulineau FP. Wei A. J. Org. Chem. 2004; 69: 3391
21f Sasaki M, Hatta M, Tanino K, Miyashita M. Tetrahedron Lett. 2004; 45: 1911
21g Shanmugam P, Miyashita M. Org. Lett. 2003; 5: 3265
21h Allwein SP, Cox JM, Howard BE, Johnson HW. B, Rainier JD. Tetrahedron 2002; 58: 1997
21i Rainier JD, Cox JM. Org. Lett. 2000; 2: 2707

22 The stereochemistry of the phenyl group of 18a was surmised on the basis of the reaction mechanism and was supported by nOe data (see SI).

23a Izquierdo J, Rodríguez S, González FV. Org. Lett. 2011; 13: 3856
23b Tanino K, Takahashi M, Tomata Y, Tokura H, Uehara T, Narabu T, Miyashita M. Nat. Chem. 2011; 3: 484
23c Jung ME, Marquez R. Tetrahedron Lett. 1999; 40: 3129

24 rac-(4R,5S,6R,7R)-3-{[(4-tert-Butylphenyl)sulfanyl]methyl}-7-(chloromethyl)-6-methoxy-4-methyl-4-phenyl-4,5,6,7-tetrahydro-2-benzofuran-5-ol (17a) and rac-(4S,6R,7R)-3-{[(4-tert-Butylphenyl)sulfanyl]methyl}-7-(chloromethyl)-6-methoxy-4-phenyl-6,7-dihydro-2-benzofuran-5(4H)-one (18a) A 1.0 M solution of DIBAL-H in hexane (0.97 mL, 1.0 mmol) was slowly added over 5 min to a solution of a 1:1 mixture of 15a and 15a′ (0.32 g, 0.66 mmol) in anhyd CH₂Cl₂ (6.6 mL) at –78 °C, and the mixture was stirred at –78 °C for 15 min. MeOH (0.4 mL) was added, and the mixture was stirred vigorously at –78 °C for 30 min then warmed to 0 °C. 2 N aq HCl was added at 0 °C, and the mixture was stirred vigorously at rt. The organic layer was separated, and the aqueous layer was extracted with CH₂Cl₂. The combined organic layers were dried (Na₂SO₄), filtered, and concentrated in vacuo. The residue was dissolved in anhyd CH₂Cl₂ (6.7 mL), and the solution was cooled to 0 °C. MsCl (0.079 mL, 1.01 mmol) and Et₃N (0.28 mL, 2.0 mmol) were added, and the mixture was stirred at 0 °C for 10 min. Sat aq NaHCO₃ was then added, and the mixture was vigorously stirred at 0 °C. The organic layer was separated, and the aqueous layer was extracted with CH₂Cl₂. The combined organic layers were dried (Na₂SO₄), filtered, and concentrated in vacuo. The residue was dissolved in 1:1 anhyd toluene–hexane (7.4 mL), and the mixture was cooled to –100 °C. A 2.0 M solution of AlMe₃ in toluene (1.23 mL, 2.5 mmol) was added at –100 °C over 10 min, and the mixture was stirred at –100 °C for 2 h. 2 N aq HCl was added at 0 °C, and the mixture was vigorously stirred. The organic layer was separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were dried (Na₂SO₄), filtered, and concentrated in vacuo. The crude material was purified by flash column chromatography [silica gel, hexane–EtOAc (12:1 to 10:1)] to afford 17a as a yellow oil [yield: 0.135 g (37%)] and 18a as a colorless oil [yield: 21 mg (6%)]. 17a IR (neat): 3480 cm^–1. ¹H NMR (500 MHz, acetone-d ₆): δ = 7.53 (d, J = 1.5 Hz, 1 H), 7.31–7.29 (m, 2 H), 7.27–7.23 (m, 4 H), 7.19–7.13 (m, 3 H), 4.26 (d, J = 5.0 Hz, 1 H), 4.06 (dd, J = 5.0, 1.5 Hz, 1 H), 3.98 (dd, J = 10.5, 7.0 Hz, 1 H), 3.93 (dd, J = 10.5, 7.5 Hz, 1 H), 3.78 (dd, J = 4.5, 1.5 Hz, 1 H). 3.74 (d, J = 13.5 Hz, 1 H), 3.57 (d, J = 13.5 Hz, 1 H), 3.47 (s, 3 H), 3.36–3.29 (m, 1 H), 1.78 (s, 3 H), 1.27 (s, 9 H). ¹³C NMR (125 MHz, acetone-d ₆): δ = 150.4, 149.0, 146.9, 138.0, 133.7, 130.9, 128.8, 128.2, 126.9, 126.8, 126.7, 123.5, 80.4, 80.0, 59.6, 45.4, 44.8, 40.3, 34.9, 32.0, 31.4, 22.5. HRMS (MALDI): m/z calcd [M + Na]⁺ for C₂₈H₃₃ ³⁵ClNaO₃S: 507.1731; found: 507.1731. 18a IR (neat): 1732 cm^–1. ¹H NMR (500 MHz, acetone-d ₆): δ = 7.60 (s, 1 H), 7.42–7.38 (m, 2 H), 7.31–7.22 (m, 3 H), 7.16–7.12 (m, 2 H), 7.04–7.00 (m, 2 H), 4.18 (d, J = 5.0 Hz, 1 H), 3.86 (dd, J = 11.0, 5.0 Hz, 1 H), 3.85 (s, 1 H), 3.70–3.64 (m, 1 H), 3.68 (d, J = 14.0 Hz, 1 H), 3.59 (dd, J = 11.0, 7.5 Hz, 1 H), 3.23 (s, 3 H), 3.22 (d, J = 14.0 Hz, 1 H), 1.32 (s, 9 H). ¹³C NMR (125 MHz, acetone-d ₆): δ = 204.7, 152.1, 148.1, 139.1, 138.0, 133.9, 132.1, 130.3, 129.0, 127.9, 126.9, 122.0, 120.6, 83.0, 58.3, 52.3, 44.9, 41.2, 35.1, 32.1, 31.5. HRMS (MALDI): m/z [M + Na]⁺ calcd for C₂₇H₂₉ ³⁵ClNaO₃S: 491.1420; found: 491.1418.

For recent examples of domino dynamic kinetic resolution/IMDA reactions, see:

25a Tsuchimochi I, Hori S, Takeuchi Y, Egi M, Satoh T, Kanomata K, Ikawa T, Akai S. Synlett 2021; 32: 822
25b Sugiyama K, Kawanishi S, Oki Y, Kamiya M, Hanada R, Egi M, Akai S. Bioorg. Med. Chem. 2018; 26: 1378

Zusatzmaterial

Supporting Information